InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward
InVivo Therapeutics Holdings Corp. (NVIV)
Last invivo therapeutics holdings corp. earnings: 5/7 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
invivotherapeutics.com/investor-relations/press-releases
Company Research
Source: Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the latest results from The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury). The primary endpoint of the study is defined as improvement in ASIA Impairment Scale (AIS) grade from baseline for all evaluable patients at the six-month visit. Nineteen patients have been implanted with the Neuro-Spinal Scaffold. Three patients died within two weeks of implantation. The 16 evaluable patients have now all reached the six-month primary endpoint visit. Seven of the 16 (43.8%) evaluable patients had an AIS grade improvement from baseline at six months. The Objective Performance Criterion (study success definition) for the study was a 25% AIS conversion rate based on the published conversion rates f
Show less
Read more
Impact Snapshot
Event Time:
NVIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVIV alerts
High impacting InVivo Therapeutics Holdings Corp. news events
Weekly update
A roundup of the hottest topics
NVIV
News
- InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
NVIV
Sec Filings
- 2/14/24 - Form SC
- 2/13/24 - Form SC
- 2/7/24 - Form 4/A
- NVIV's page on the SEC website